Sponsor:
Enteris BioPharma Inc.
Code:
NCT05096065
Conditions
Endometriosis
Eligibility Criteria
Sex: Female
Age: 18 - 49
Healthy Volunteers: Not accepted
Interventions
Leuprolide Oral Tablet - 120 mg - QD- Treatment A
Leuprolide Oral Tablet - 80 mg - QD - Treatment B
Leuprolide Oral Tablet - 60 mg - QD - Treatment C
Leuprolide Oral Tablet - 60 mg - BID - Treatment D
Leuprolide Oral Tablet - 40 mg - BID - Treatment E
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations